Enigma Diagnostics Announces Patent Licence With Applied Biosystems
Enigma Diagnostics Limited announced that it has signed a third licence agreement with Applied Biosystems.
The licence provides Enigma with access to claims of US Patent No. 5,928,907 that describe methods for monitoring nucleic acid amplification in real-time. This is the first such licence Applied Biosystems has granted to the method claims of the '907 patent.
This complements Enigma's existing licence under certain patents owned by Applied Biosystems for real-time PCR thermal cyclers.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.